More SEC Filings
View Older Stories View Newer Stories-
Form 6-K ASE Technology Holding For: Jun 10
-
Form 8-K AAON, INC. For: Jun 10
-
Form 6-K TAKEDA PHARMACEUTICAL For: Jun 10
-
Form S-1/A Australian Oilseeds Hold
-
Form 424B2 Lloyds Banking Group
-
Form 424B2 Air Products & Chemicals
-
Form 6-K WESTPAC BANKING CORP For: Jun 10
-
Form 6-K CHUNGHWA TELECOM CO LTD For: Jun 10
-
Form 8-K RECURSION PHARMACEUTICAL For: Jun 10
-
Form 6-K ING GROEP NV For: Jun 10
-
Form 6-K MAG SILVER CORP For: Jun 10
-
Form 6-K Intercorp Financial Serv For: Jun 09
-
Form 8-K Brand Engagement Network For: Jun 05
-
Form 6-K MIZUHO FINANCIAL GROUP For: Jun 10
-
Form 6-K TOYOTA MOTOR CORP/ For: Jun 10
-
Form 6-K HDFC BANK LTD For: Jun 09
-
Form 8-K IONIS PHARMACEUTICALS For: Jun 05
-
Form 3 Anteris Technologies For: Jun 07 Filed by: Moss Gregory S.
-
Form 3 Anteris Technologies For: Jun 07 Filed by: Roberts David B
-
Form CB/A YiChang HEC ChangJiang Filed by: Sunshine Lake Pharma Co., Ltd.
-
Form 6-K JBDI Holdings Ltd For: Jun 10
-
Form 424B2 JPMORGAN CHASE & CO
-
Form EFFECT Nuwellis, Inc.
-
Form EFFECT Artificial Intelligence
-
Form EFFECT Julong Holding Ltd
-
Form 6-K CHINA YUCHAI INTERNATION For: Jun 10
-
Form EFFECT AMG Pantheon Infrastruct
-
Form EFFECT Blue Water Acquisition
-
Form QUALIF Masterworks Vault 4,
-
Form EFFECT 707 Cayman Holdings Ltd.
-
Form EFFECT ADIAL PHARMACEUTICALS,
-
Form D Infusion LLC - Series 1
-
Form EFFECT FOXO TECHNOLOGIES INC.
-
Form EFFECT SIEBERT FINANCIAL CORP
-
Form EFFECT BIOLARGO, INC.
-
Form S-3 Bitwise 10 Crypto Index
-
Form QUALIF Arrived SFR Genesis Fund
-
Form 8-K AMPHENOL CORP /DE/ For: Jun 09
-
Form EFFECT FIRST OF LONG ISLAND
-
Form 6-K Tencent Music Entertainm For: Jun 10
-
Form 6-K GERDAU S.A. For: Jun 09
-
Form S-4/A Avalon GloboCare Corp.
-
Form 1-A POS ModVans Inc.
-
Form 6-K CERAGON NETWORKS LTD For: Jun 10
-
Form 424B3 HarbourVest Private Inve
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 6-K Mogo Inc. For: Jun 09
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 6-K ASCENTAGE PHARMA GROUP For: Jun 09
-
Form D REEP Strategic Equity

